PharmaShots Weekly Snapshot (Nov 30 - Dec 04, 2020)
Richter Acquires Janssen's Evra Transdermal Contraceptive Patch Assets for $263.5M
Published: Dec 3, 2020 | Tags: Asset Purchase Agreement, Evra, Gedeon Richter, Janssen Pharmaceutical, Signs, Transdermal Contraceptive Patch Assets, Treat
Published: Dec 3, 2020 | Tags: ATLANTIS, Doxorubicin, Jazz Pharma, P-III, patients, PharmaMar, results, SCLC, study, Zepzelca
reMYND Commences P-l Study of RES19-T for Alzheimer's Disease
Published: Dec 3, 2020 | Tags: Alzheimer, Commencement, First-in-Human, P-l, reMYND, RES19-T, Treatment, Trial
Abbott's FreeStyle Libre 2 Receives Health Canada's Approval for Adults and Children with Diabetes
Published: Dec 2, 2020 | Tags: Abbott, Adults, approval, canada, Children, Diabetes, FreeStyle Libre 2, health, receives
Exactech Acquires Muvr and its Digital Health Tech for Orthopedic Practices
Published: Dec 2, 2020 | Tags: Acquires, Exactech, Muvr Labs, Orthopedic
Published: Dec 3, 2020 | Tags: Janssen, Reports, BLA Submission, Amivantamab, US FDA, Metastatic NSCLC, EGFR Exon 20 Insertion Mutations
Merck KGaA Collaborates with Artios Pharma for DNA Damage Cancer Therapies
Published: Dec 3, 2020 | Tags: Agreement, Artios Pharma, Damage, DNA, Merck KGaA, Novel, Oncology, Response, Signs, Targets
Janssen Acquires Rights to Hemera's HMR59 for Late-Stage Age-Related Macular Degeneration
Published: Dec 2, 2020 | Tags: Acquires, Age Related Macular Degeneration, Biosciences, Gene, Hemera, Janssen, Late, Novel, Pioneering, Rights, Solutions, Stage, therapy, Treatment
AstraZeneca to Unveil its Robust Pipeline of Breast Cancer at SABCS
Published: Dec 3, 2020 | Tags: AstraZenca, DESTINY-Breast01, Enhertu, HER2 -Positive Metastatic Breast Cancer, HR, P-l, P-ll, reports, results, SERD AZD9833, SERENA-1 Study
Published: Dec 2, 2020 | Tags: AbbVie, Agreement, Develop, Discover, E3 Degraders, Frontier Medicines, Novel Therapies, Sign
Published: Dec 2, 2020 | Tags: (Anti-SARS-CoV-2 S), COVID-19, Elecsys, EUA, Receive, Roche's, US FDA's
Pfizer & BioNTech Receives MHRA's EUA for BNT162b2 Against COVID-19
Published: Dec 2, 2020 | Tags: Against, BioNTech, BNT162b2, COVID-19 COVID-19, EUA, MHRA, Pfizer, receives, Regulatory, UK
Published: Dec 2, 2020 | Tags: (pralsetinib), Advanced or Metastatic RET-Mutant, Gavreto, receives, RET Fusion-Positive Thyroid Cancers, Roche's, US FDA's Approval
AstraZeneca to Divest European Rights of Crestor (rosuvastatin) to Grünenthal for ~$350M
Published: Dec 1, 2020 | Tags: $350M, Acquire, Agreement, AstraZeneca, CRESTOR, European, Grünenthal, Rights, rosuvastatin, Signs
Published: Dec 1, 2020 | Tags: Casirivimab, Collaborates, COVID-19 Antibody Cocktail, Delivery, Gene Therapy Platform, Imdevimab, Investigate, Penn, Regeneron
Boston Scientific to Divest BTGs Specialty Pharma Business for ~$800M
Published: Dec 1, 2020 | Tags: Agreement, Boston, BTG, business, International, Pharmaceuticals, Scientific, Sell, Signs, Specialty, Stark
BioNTech and Pfizer Report CMA Submission of BNT162b2 to EMA for COVID-19
Published: Dec 1, 2020 | Tags: application, BioNTech, BNT162b2, CMA, Covid-19 Vaccine, EMA, Pfizer, Submitted
Published: Dec 1, 2020 | Tags: Adults, approval, Genentech Xolair, Nasal Polyps, Novartis, omalizumab, receives, US FDA
Published: Nov 30, 2020 | Tags: Discover, Eisai, Novel Small Molecule, Research Agreement, Sign, Synucleinopathies, Wren Therapeutics
AstraZeneca Initiates P-IIb Study of ION449 (AZD8233) to Lower LDL-cholesterol
Published: Nov 30, 2020 | Tags: Antisense, AstraZeneca, Initiates, ION449, Ionis, LDL-C, Lower, Medicine, P-IIb, PCSK9, reports, study, Targeting
Kaia Health Allied with Chiesi Group to Commercialize COPD App in Europe
Published: Nov 30, 2020 | Tags: Agreement, Chiesi Group, Europe, Kaia Health, Sign
Member of COVID R&D Alliance Report the First Patient Enrollment in COMMUNITY Study
Published: Dec 1, 2020 | Tags: Amgen, COMMUNITY, COVID-19, enrolled, First, Patient, patients, reports, Takeda, Trial, UCB
Sanofi's Dupixent (dupilumab) Receives EC's Approval for Children with Severe Atopic Dermatitis
Published: Nov 30, 2020 | Tags: (dupilumab), Atopic Dermatitis, Dupixent, European Commission Approval, receives, Sanofi's
Moderna to Seek the FDA and EMA's EUA for mRNA-1273 and Shows 100% Efficacy in P-III COVE-Study
Published: Nov 30, 2020 | Tags: 100%, 94.1%, COVID-19, Effective, EUA, Filing, Moderna, mRNA, Severe, Shows, Today, Us FDA, vaccine
AstraZeneca's Forxiga (dapagliflozin) Receives MHLW's Approval for Chronic Heart Failure
Published: Nov 30, 2020 | Tags: approval, AstraZeneca, Chronic Heart Failure, dapagliflozin, Forxiga, Japan, MHLW, receives, Treatment
AbbVie and Eisai's Humira (adalimumab) Receives MHLW's Approval for Pyoderma Gangrenosum
Published: Nov 27, 2020 | Tags: (adalimumab), AbbVie, Additional, Eisai, Humira, Indication, MHLW Approval, Pyoderma Gangrenosum, receives
Shionogi and Nagasaki University Collaborate with the Kitasato Institute for Antimalarial Drugs
Published: Nov 25, 2020 | Tags: Agreement, Antimalarial, drugs, Kitasato Institute, Nagasaki, Shionogi, Signs, University
Published: Nov 27, 2020 | Tags: (baloxavir marboxil), approval, Infection, Influenza Virus, MHLW, Post-Exposure Prophylaxis, receives, Shionogi, sNDA, Treat, Xofluza
Moderna Amends its Agreement with UK Government for an Additional 2M Doses of COVID-19 Vaccine
Published: Nov 29, 2020 | Tags: 2M, Additional, Against, Agreement, Amends, COVID-19, doses, Government, Moderna, mRNA, mRNA-1273, UK, vaccine
Dr. Reddy's to Divest Select Anti-Allergy brands to Dr. Reddy's in Russia and Other CIS Countries
Published: Nov 28, 2020 | Tags: Acquire, Dr. Reddy, Glenmark, Kazakhstan, Russia, Ukraine, Uzbekistan
Related Post: PharmaShots Weekly Snapshot (Nov 23 - 27, 2020)
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com